Insilico Launches AI-driven Longevity Vaccines Research for Aging-related Diseases and Human Longevity (IMAGE)

InSilico Medicine

Insilico Launches AI-driven Longevity Vaccines Research for Aging-related Diseases and Human Longevity

Caption

The program applies generative AI and programmable RNA medicine to design single-administration, self-limiting in vivo cell therapies that clear the earliest culprit cells of age-related disease.

Credit

Insilico Medicine

Usage Restrictions

Insilico Medicine

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.